Clinical Trial: Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma

U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07840092) titled 'Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma' on Sept. 14.

Brief Summary: Observational Model: Cohort Time Perspective: Other (prospective and retrospective data/sample collection) Primary Purpose: Other (biomarker validation for treatment response and recurrence prediction) Biospecimen Retention: Samples With DNA Biospecimen Description: Residual tissue, wax blocks/slides, residual puncture/surgical materials, and residual blood from routine testing; additional peripheral blood, 5-10 mL per collection, may be collected if needed after separate informed consent.

Enrollment: 500 ...